Search research articles
Contact Us
Filters
Showing results (611-620 of 3,665) with videos related to
Page
of 367
Sort By:
The Journal of Antimicrobial Chemotherapy
|
September 1, 1988
Antimicrobial activity of LY163892, an orally administered 1-carbacephem
R N Jones, A L Barry
Diagnostic Microbiology and Infectious Disease
|
January 5, 2002
Assessment of BMS284756 MIC and 5-microg disk diffusion quality control studies tested against seven American type culture collection strains
D J Biedenbach, R N Jones,
Lancet (London, England)
|
December 19, 2001
Oxazolidinone antibiotics
D J Diekema, R N Jones
Diagnostic Microbiology and Infectious Disease
|
June 19, 2001
Can antimicrobial susceptibility testing results for ciprofloxacin or levofloxacin predict susceptibility to a newer fluoroquinolone, gatifloxacin?: Report from The SENTRY Antimicrobial Surveillance Program (1997-99)
R N Jones, M A Pfaller,
Journal of Psychopharmacology (Oxford, England)
|
September 22, 2001
A case of depersonalization-derealization syndrome during treatment with quetiapine
J Sarkar, N Jones, G Sullivan
International Journal of Antimicrobial Agents
|
May 15, 2002
Antimicrobial susceptibility of inducible AmpC beta-lactamase-producing Enterobacteriaceae from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Programme, Europe 1997-2000
Michael A Pfaller, Ronald N Jones,
Diagnostic Microbiology and Infectious Disease
|
August 2, 2002
Evaluation of in vitro susceptibility testing criteria for gemifloxacin when tested against Haemophilus influenzae strains with reduced susceptibility to ciprofloxacin and ofloxacin
Douglas J Biedenbach, Ronald N Jones
The British Journal of General Practice : the Journal of the Royal College of General Practitioners
|
June 1, 1995
Heartsink patients: a study of their general practitioners
N Mathers, N Jones, D Hannay
Diagnostic Microbiology and Infectious Disease
|
March 1, 1995
National survey of the in vitro spectrum of piperacillin-tazobactam tested against more than 40,000 aerobic clinical isolates from 236 medical centers
E J Baron, R N Jones
Antimicrobial Agents and Chemotherapy
|
July 1, 1995
In vitro evaluation of DV-7751a, a new fluoroquinolone with an enhanced spectrum of activity against gram-positive aerobic organisms and anaerobes
D J Biedenbach, R N Jones
Page
of 367
Search research articles
Search
Showing results (611-620 of 3,665) with videos related to
Sort By:
Page
of 367
The Journal of Antimicrobial Chemotherapy
|
September 1, 1988
Antimicrobial activity of LY163892, an orally administered 1-carbacephem
R N Jones, A L Barry
Diagnostic Microbiology and Infectious Disease
|
January 5, 2002
Assessment of BMS284756 MIC and 5-microg disk diffusion quality control studies tested against seven American type culture collection strains
D J Biedenbach, R N Jones,
Lancet (London, England)
|
December 19, 2001
Oxazolidinone antibiotics
D J Diekema, R N Jones
Diagnostic Microbiology and Infectious Disease
|
June 19, 2001
Can antimicrobial susceptibility testing results for ciprofloxacin or levofloxacin predict susceptibility to a newer fluoroquinolone, gatifloxacin?: Report from The SENTRY Antimicrobial Surveillance Program (1997-99)
R N Jones, M A Pfaller,
Journal of Psychopharmacology (Oxford, England)
|
September 22, 2001
A case of depersonalization-derealization syndrome during treatment with quetiapine
J Sarkar, N Jones, G Sullivan
International Journal of Antimicrobial Agents
|
May 15, 2002
Antimicrobial susceptibility of inducible AmpC beta-lactamase-producing Enterobacteriaceae from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Programme, Europe 1997-2000
Michael A Pfaller, Ronald N Jones,
Diagnostic Microbiology and Infectious Disease
|
August 2, 2002
Evaluation of in vitro susceptibility testing criteria for gemifloxacin when tested against Haemophilus influenzae strains with reduced susceptibility to ciprofloxacin and ofloxacin
Douglas J Biedenbach, Ronald N Jones
The British Journal of General Practice : the Journal of the Royal College of General Practitioners
|
June 1, 1995
Heartsink patients: a study of their general practitioners
N Mathers, N Jones, D Hannay
Diagnostic Microbiology and Infectious Disease
|
March 1, 1995
National survey of the in vitro spectrum of piperacillin-tazobactam tested against more than 40,000 aerobic clinical isolates from 236 medical centers
E J Baron, R N Jones
Antimicrobial Agents and Chemotherapy
|
July 1, 1995
In vitro evaluation of DV-7751a, a new fluoroquinolone with an enhanced spectrum of activity against gram-positive aerobic organisms and anaerobes
D J Biedenbach, R N Jones
Page
of 367